McConnell Blocks Bill to Lower Drug Costs and Gets $50,0000 from Big Pharma
Tell Mitch McConnell to stop hurting Americans to line his pockets.
American Independent Reports: McConnell gets $50,000 from pharma after blocking bill to lower drug prices
In September 2018, House Speaker Nancy Pelosi announced a groundbreaking bill, the Lower Drug Costs Now Act. The bill would allow the government to negotiate with pharmaceutical companies on prescription drug costs for Medicare, restrict price hikes, and limit out-of-pocket costs. The same day, Mitch McConnell said the bill would not pass the Senate.
On Oct. 16, McConnell received a $2,500 check from Takeda Pharmaceuticals' political action committee, according to McConnell's reports to the Federal Election Commission.
The same campaign finance filings show that a few weeks after that, multinational pharmaceutical company Novartis' PAC also sent $2,500 to McConnell. Then, a PAC for another pharma company, Emergent BioSolutions, kicked in $2,500.
By the end of December, McConnell's campaign reported, he had received at least $30,000 more from the corporate political action committees of Bluebird Bio ($2,500), Boehringer Ingelheim ($5,000), Greenwich Biosciences ($2,500), Teva USA ($10,000), and UCB ($2,500).
According to filings from his Bluegrass Committee leadership PAC, Merck & Co. also contributed $5,000 to support McConnell and Sanofi donated $2,500.
That's not it. McConnell also received another $12,600 from pharmaceutical CEOs and lobbyists.
It is clear that Mitch McConnell is funding his campaign on the backs of the American people. We need to tell Mitch to do his job.
To see more content like this, help support Future Majority here.
Your Daily Round Up for February 28thGood afternoon. Here are the latest news and updates that our team at Future Majority is tracking. Another Saturday, another
#TrumpSlump Stresses Global MarketsWall Street Journal Reports: U.S. Stocks Fall on Fresh Trade Tensions U.S. stocks fall as a result of Trump's tweet saying he Infrastructure
Memo - How we got here: COVID-19 in the U.S.It’s hard to describe how events have turned in the past several weeks in the United States. What once seemed like a far-off